

Research updates from Luvaminos
Subscribe for catalog updates, new research compounds, and quality documentation releases.
For researchers and labs. No spam — unsubscribe anytime.
For Research Purposes Only
Out of StockSize
Quantity
Bundle & Save
Type
Mitochondria-derived peptide (MDP; 21–24 residues depending on translation context)
Molecular formula
C₁₁₉H₂₀₄N₃₄O₃₂S₂
Molecular weight
~2,687 g/mol
CAS number
330936-69-1
Amino acids
24
Sequence
MAPRGFSCLLLLTSEIDLPVKRRA
Modification
Cytosolic translation yields the 24-residue canonical sequence (MAPRGFSCLLLLTSEIDLPVKRRA; UniProt Q8IVG9); mitochondrial translation yields a 21-residue form (MAPRGFSCLLLLTSEIDLPVK) due to differences in the mitochondrial genetic code. Both forms have been studied. Commonly used research analogs include the S14G substitution (HNG, studied for extended in vivo stability), N-formylated Humanin (fHN, studied for receptor pharmacology), the F6A/HNGF6A substitution (abolishes IGFBP-3 binding — used to dissect interaction specificity), and D-Ser14 forms (structural studies). Cys8 and Leu12 are noted as functionally critical residues in mechanistic work.
Humanin has been studied as a peptide with both intracellular and extracellular binding partners. Intracellularly, it has been characterized as a binding partner for Bcl-2-family proteins — including BAX, BID/tBID, and BimEL — and for IGFBP-3; structural studies demonstrate that Humanin can induce conformational changes in BAX and recruit it into higher-order β-sheet fiber assemblies, work that provides structural context for the mitochondrial outer-membrane permeabilization (MOMP) literature. Extracellularly, it has been examined as a ligand at members of the G-protein-coupled receptor (GPCR) family and at a trimeric cytokine-receptor complex; cryo-EM and biophysical studies have resolved receptor-bound forms at atomic resolution, mapping the binding interface and the structural basis for competitive ligand models.
Lyophilized
20°C (-80°C long term)
lyophilized powder typically stable ~24 months under dry, sealed conditions.
Native Humanin is reported to have a short circulating half-life in vivo that varies by species and analog form; the S14G (HNG) analog has been studied for extended in vivo stability in animal models. Protect from light and moisture; Cys8 is an oxidation-sensitive residue.
Reviews
Karachaliou CE, Livaniou E. (2023). Biology (Basel)
Systematic review. (2023). Biology (Basel)
Reviews
Miller B, Kim SJ, Kumagai H, et al. (2022). J Clin Invest
Lee C, Yen K, Cohen P. (2013). Trends Endocrinol Metab
Yen K, Lee C, Mehta H, Cohen P. (2013). J Mol Endocrinol
Clinical
Miller B, Kim SJ, Cao K, et al. (2024). Aging Cell
Yen K, Wan J, Mehta HH, et al. (2018). Sci Rep
Primary research
Zhu Y, Lin X, Zong X, et al. (2022). Nat Commun
Yen K, Mehta HH, Kim SJ, et al. (2020). Aging (Albany NY)
Morris DL, Kastner DW, Johnson S, et al. (2019). J Biol Chem
Kuliawat R, Klein L, Gong Z, et al. (2013). FASEB J
Muzumdar RH, Huffman DM, Calvert JW, et al. (2010). Arterioscler Thromb Vasc Biol
Muzumdar RH, Huffman DM, Atzmon G, et al. (2009). PLoS One
Hashimoto Y, Kurita M, Aiso S, Nishimoto I, Matsuoka M. (2009). Mol Biol Cell
Luciano F, Zhai D, Zhu X, et al. (2005). J Biol Chem
Zhai D, Luciano F, Zhu X, Guo B, Satterthwait AC, Reed JC. (2005). J Biol Chem
Harada M, Habata Y, Hosoya M, et al. (2004). Biochem Biophys Res Commun
Ying G, Iribarren P, Zhou Y, et al. (2004). J Immunol
Guo B, Zhai D, Cabezas E, et al. (2003). Nature
Ikonen M, Liu B, Hashimoto Y, et al. (2003). Proc Natl Acad Sci USA
Hashimoto Y, Niikura T, Ito Y, et al. (2001). J Neurosci
Hashimoto Y, Niikura T, Tajima H, et al. (2001). Proc Natl Acad Sci USA
Also known as: HN, MT-RNR2 peptide, mitochondria-derived peptide
View this compound in the Research Library →Frequently Bought Together